Thiolated polyacrylic acid-modified iron oxide nanoparticles for in vitro labeling and MRI of stem cells - PubMed (original) (raw)
Thiolated polyacrylic acid-modified iron oxide nanoparticles for in vitro labeling and MRI of stem cells
A Vetter et al. J Drug Target. 2011 Aug.
Abstract
Purpose: The purpose of this study was to develop and characterize new surface-modified iron oxide nanoparticles demonstrating the efficiency to be internalized by human endothelial progenitor cells (EPCs) from umbilical cord blood.
Methods: Iron oxide nanoparticles were coated with polyacrylic acid-cysteine (PAA-Cys) by either in situ precipitation or postsynthesis. The nanoparticles were characterized by X-ray powder diffraction. EPCs were labeled with PAA-Cys-modified iron oxide nanoparticles or with uncoated nanoparticles. The relaxivity of uncoated and coated iron oxide nanoparticles as well as EPCs labeled with PAA-Cys-modified iron oxide were determined.
Results: Addition of PAA-Cys increased the particle size from 10.4 to 144 and 197 nm, respectively. The X-ray powder diffraction pattern revealed that the particles consist of Fe(3)O(4) with a spinal structure. Postsynthesis coated particles showed a cellular uptake of 85% and 15.26 pg iron/cell. For both types of particles the relaxivity ratio was at least 2-fold higher than that of the gold standard Resovist(®).
Conclusion: The PAA-Cys coated iron oxide nanoparticles are a promising tool for labeling living cells such as stem cells for diagnostic and therapeutic application in cell-based therapies due to their high relaxivities and their easy uptake by cells.
Similar articles
- D-mannose-modified iron oxide nanoparticles for stem cell labeling.
Horak D, Babic M, Jendelová P, Herynek V, Trchová M, Pientka Z, Pollert E, Hájek M, Syková E. Horak D, et al. Bioconjug Chem. 2007 May-Jun;18(3):635-44. doi: 10.1021/bc060186c. Epub 2007 Mar 20. Bioconjug Chem. 2007. PMID: 17370996 - Efficient MRI labeling of endothelial progenitor cells: design of thiolated surface stabilized superparamagnetic iron oxide nanoparticles.
Shahnaz G, Kremser C, Reinisch A, Vetter A, Laffleur F, Rahmat D, Iqbal J, Dünnhaupt S, Salvenmoser W, Tessadri R, Griesser U, Bernkop-Schnürch A. Shahnaz G, et al. Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):346-55. doi: 10.1016/j.ejpb.2013.02.010. Epub 2013 Mar 7. Eur J Pharm Biopharm. 2013. PMID: 23481176 - Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling.
Babic M, Horák D, Trchová M, Jendelová P, Glogarová K, Lesný P, Herynek V, Hájek M, Syková E. Babic M, et al. Bioconjug Chem. 2008 Mar;19(3):740-50. doi: 10.1021/bc700410z. Epub 2008 Feb 21. Bioconjug Chem. 2008. PMID: 18288791 - Magnetic labeling, imaging and manipulation of endothelial progenitor cells using iron oxide nanoparticles.
Gazeau F, Wilhelm C. Gazeau F, et al. Future Med Chem. 2010 Mar;2(3):397-408. doi: 10.4155/fmc.09.165. Future Med Chem. 2010. PMID: 21426174 Review. - Iron oxide based MR contrast agents: from chemistry to cell labeling.
Laurent S, Boutry S, Mahieu I, Vander Elst L, Muller RN. Laurent S, et al. Curr Med Chem. 2009;16(35):4712-27. doi: 10.2174/092986709789878256. Curr Med Chem. 2009. PMID: 19903138 Review.
Cited by
- Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis.
Shahnaz G, Edagwa BJ, McMillan J, Akhtar S, Raza A, Qureshi NA, Yasinzai M, Gendelman HE. Shahnaz G, et al. Nanomedicine (Lond). 2017 Jan;12(2):99-115. doi: 10.2217/nnm-2016-0325. Epub 2016 Nov 23. Nanomedicine (Lond). 2017. PMID: 27879160 Free PMC article. - Thiolated Nanoparticles for Biomedical Applications: Mimicking the Workhorses of Our Body.
Hock N, Racaniello GF, Aspinall S, Denora N, Khutoryanskiy VV, Bernkop-Schnürch A. Hock N, et al. Adv Sci (Weinh). 2022 Jan;9(1):e2102451. doi: 10.1002/advs.202102451. Epub 2021 Nov 12. Adv Sci (Weinh). 2022. PMID: 34773391 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical